Tag: pgxl bankruptcy

$26 Million Recoupment from Medicare Audit Hammers Pharmacogenomic Lab

By Joseph Burns, from the Volume XXIV, No. 1 – January 9, 2017 issue

CEO SUMMARY: After Pharmacogenetics Diagnostic Laboratory LLC was audited by a Medicare Zone Program Integrity Contractor (ZPIC), it faced a $26 million repayment demand. The lab company appealed and asked for a redetermination, then filed for Chapter 11 bankruptcy protection. These developments should be a concern to all labs offering pharmacogenomic testing to Medicare patients.

View Article

Pharmacogenomic Testing Draws $26 Million Recoupment from Medicare Audit

By Mary Van Doren

This is an excerpt from a 1,340-word article in the January 9 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group.
CEO SUMMARY: Pharmacogenomic testing is expected to be a linchpin to the practice of precision

View Article

Volume XXVI No. 5 – April 8, 2019

IT'S A FIRST FOR THE CLINICAL LAB INDUSTRY - and American industry as a whole. This issue exclusively reveals that after two years of testing, a lab has achieved the first revenue-generating flight of an unmanned drone in the U.S. Now, the lab's transport of supplies and specimens can safely bypass traffic regularly. Remarkably, the project has involved the cooperation of UPS and both the FAA and state regulators. Also, TDR reports that another government initiative, the National Correct Coding Initiative, has apparently gone awry. Labs could be harmed if they submit claims incorrectly based on the NCCI.

See the full table of contents

Tag: pgxl bankruptcy

Enter Your Login Credentials